🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, glowing reviews and detailed guides for mixing or injecting at residence.

After moments of entering one community, a vendor shared contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Information and Pricing

Within these groups, posts show dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to potentially serious health risks”.